Budesonide
National NHS prescribing (Prescription Cost Analysis) · Chronic bowel disorders
Budesonide was ranked 523rd of 1,794 medicines by items in March 2026, with 8,647 items, up 10.3% on a year earlier.
8,647items
Dispensed in March 2026
NHSBSA Prescription Cost Analysis
£835,724
Net ingredient cost · March 2026
NHSBSA PCA
101,198items
Dispensed in the last 12 months
NHSBSA PCA
Figure 1. Budesonide: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to March 2026
Embed this chart
Top presentations, March 2026
The individual products dispensed under Budesonide, by items this month.
| Presentation | Items | Net ingredient cost |
|---|---|---|
| Budenofalk 3mg gastro-resistant capsules | 3,929 | £203,879 |
| Budesonide 3mg gastro-resistant modified-release capsules | 1,556 | £126,161 |
| Budenofalk 2mg/application foam enema | 1,300 | £151,284 |
| Cortiment 9mg modified-release tablets | 733 | £75,273 |
| Jorveza 1mg orodispersible tablets | 567 | £155,109 |
| Jorveza 0.5mg orodispersible tablets | 173 | £53,149 |
| Budesonide 4mg suppositories | 167 | £34,901 |
| Budenofalk 4mg suppositories | 97 | £22,532 |
| Budenofalk 9mg gastro-resistant granules sachets | 88 | £9,452 |
| Entocort 2mg/100ml enema | 34 | £3,534 |
| Entocort CR 3mg capsules | 3 | £450 |
Compare Budesonide with
Other medicines in the same BNF section, by prescribing volume.